A higher density of caspase-3-labeled podocytes were observed in glomeruli of patients from the FSGS group and from the MCD group compared to the control group (Fig 3A and 3B, p < 0.0001, F = 23.69, Table 3). This evidence concerns the gene CASP3 and focal segmental glomerulosclerosis.